| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |